Updated:
Prism Capital
Prism Capital is a Chicago-based private equity firm with $190 million in assets under management. We provide subordinated debt to lower middle market...
Prism Capital
Prism Capital is a Chicago-based private equity firm with $190 million in assets under management. We provide subordinated debt to lower middle market companies through the Prism Mezzanine Fund and expansion capital to smaller growing companies through our equity fund, Prism Opportunity Fund. We partner with superior management teams and private equity professionals to finance growth, recapitalizations, and buyouts.
General information
Firm type
Private Equity
Year founded
1999
AUM
Undisclosed
Location
Region
North America
Country
United States
City
Glenview
Corporate office
2700 Patriot Boulevard, Suite 250, Glenview, Illinois 60026, United States
Principals
Robert Finkel
Managing Partner
Bill Harlan
Partner
Steve Vivian
Partner
Sector focus
Frequently asked questions
Is Prism Capital still making new investments?
No. The firm began winding down its funds in 2011 and no longer deploys new capital. The remaining partners are focused on managing the residual portfolio assets on behalf of their limited partners. This process has been publicly stated on the firm's website.
Who runs investment decisions at Prism Capital?
Robert Finkel leads the firm as Managing Partner. Bill Harlan and Steve Vivian serve as Partners. The three are the named contacts for all firm matters, including the management of the remaining fund assets during the wind-down.
What investment strategies did Prism Capital operate?
Prism managed two distinct funds. The Prism Opportunity Fund pursued growth equity investments, ultimately backing 14 companies. The Prism Mezzanine Fund provided subordinated debt to lower-middle-market companies, funding 26 businesses. The firm invested in over 40 portfolio companies across both vehicles during its active period.
Which notable companies did the Prism Opportunity Fund invest in?
The portfolio included SecurePipe, which merged with Trustwave, and Fieldglass, which sold to Madison Dearborn Partners. The fund also held Celleration, sold to Alliqua BioMedical; HighBeam Research, sold to Gale; and SterilMed, acquired by Great Hill Partners and Primus Capital. Banner Service Corp was another confirmed investment.
What happened to Prism Capital's mezzanine fund portfolio?
The Prism Mezzanine Fund invested in 26 lower-middle-market businesses. One of the most recognized outcomes was Angie's List, which completed an initial public offering. Other investments included Trans-Coil, Hi-Tech Manufacturing, Hill & Valley, Ott-Lite, and DeIorio.
Profile maintained by Altss using OSINT (open-source intelligence), regulatory filings, licensed data partners, and verified direct submissions. Read the methodology. Last updated: . Continuous refresh with full update cycles at least every 30 days.
Need institutional-grade insight on private equity firms?
Altss delivers:
Prefer a guided tour?
We’ll walk you through: